Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Jubilant Pharmova Ltd.
NSE: JUBLPHARMA
|
BSE: 530019
|
ISIN: INE700A01033
|
Industry: Pharmaceuticals
Analyst Buy
|
Mid-range Performer
1045.6000
-20.70
(
-1.94
%)
NSE
Jan 16, 2026
15:31 PM
30.37% Gain from 52W Low
Volume:
59,695
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Jubilant Pharmova Ltd.
15 Jan 2026
Analyst Buy
1045.60
-1.94%
JUBILANT PHARMOVA LTD.
Buy:
Jubilant Pharmova Ltd.
by
Ventura
Target: 1557 | Upside : 48.9%
Ventura
Formulating Growth and Scaling Across Pharma Verticals
Ventura released a Buy report for Jubilant Pharmova Ltd. with a price target of 1557.0 on 15 Jan, 2026.
More from Jubilant Pharmova Ltd.
Recommended
Five Interesting Stocks Today - January 16, 2026
The Baseline |
16 Jan 2026, 06:00PM
Market closes higher, buoyed by a rally in IT stocks
Trendlyne Marketwatch |
16 Jan 2026, 04:20PM
Earnings Call Transcript - Q4FY20 for Jubilant Life Sciences
|
30 May 2020